What is moxifloxacin hydrochloride?
Moxifloxacin hydrochloride is anprescription medicine approved by the U.S. (FDA) for the treatment of certain bacterial infections, such as acute worsening of chronic bronchitis, acute sinus infections, community-acquired , plague, and skin and abdominal infections.
Certain bacterial respiratory diseases (such as community-acquired pneumonia) are opportunistic infections (OIs) of HIV. An OI is an What is an Opportunistic Infection? fact sheet.that occurs more frequently or is more severe in people with weakened immune systems—such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the HIVinfo
How is moxifloxacin hydrochloride used in people with HIV?
The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV include recommendations on the uses of moxifloxacin hydrochloride to:
- Mycobacterium avium complex (MAC) infection
- Active (TB) disease
- Certain bacterial infections, such as salmonellosis (also known as infection), , and
- Certain bacterial respiratory diseases, including community-acquired pneumonia
- Disseminated MAC infection from recurring
What should I tell my health care provider before taking moxifloxacin hydrochloride?
Before taking moxifloxacin hydrochloride, tell your health care provider:
- If you are allergic to moxifloxacin hydrochloride or any other medicines.
- About any medical conditions you have or have had, for example, or problems.
- About anything that could affect your ability to take medicines, such as difficulty swallowing or remembering to take pills, or any health conditions that may prevent you from receiving medicine by .
- If you are pregnant or plan to become pregnant. Talk to your health care provider about the risks and benefits of taking moxifloxacin hydrochloride during pregnancy.
- If you are breastfeeding or plan to breastfeed. Do not breastfeed if you have HIV.
- About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Moxifloxacin hydrochloride may affect the way other medicines or products work, and other medicines or products may affect how moxifloxacin hydrochloride works. Ask your health care provider if there are interactions between moxifloxacin hydrochloride and the other medicines you take.
Ask your health care provider about possible side effects from moxifloxacin hydrochloride. Your health care provider will tell you what to do if you have side effects.
How should I take moxifloxacin hydrochloride?
Take moxifloxacin hydrochloride according to your health care provider’s instructions. Your health care provider will tell you how much moxifloxacin hydrochloride to take and when to take it. Before you start moxifloxacin hydrochloride and each time you get a refill, read any printed information that comes with your medicine.
How should moxifloxacin hydrochloride be stored?
- Store moxifloxacin hydrochloride tablets at 59°F to 86°F (15°C to 30°C) and away from moisture (humidity).
- Store moxifloxacin hydrochloride injection solution at 59°F to 86°F (15°C to 30°C). Do not refrigerate ready-to-use bags of moxifloxacin hydrochloride solution.
- Do not use moxifloxacin hydrochloride if the original seal over the medicine container is broken or missing.
- Throw away moxifloxacin hydrochloride that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
- Keep moxifloxacin hydrochloride and all medicines out of reach of children.
Where can I find more information about moxifloxacin hydrochloride?
More information about moxifloxacin hydrochloride is available:
- Recommendations on the HIV-related uses of moxifloxacin hydrochloride, from the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV, prepared by the , the , and the HIV Medicine Association of the Diseases Society of America
- Moxifloxacin hydrochloride-related research studies, from
Last Reviewed: July 2, 2019